Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak
ConditionEsophagojejunal Anastomotic Leak
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorUkrainian Society of Clinical Oncology
About this trial
The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following:
Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.
Eligibility criteria
Qualifiers
patients who developed esophago-jejunal anastomotic leak less than 50% of circumference of anastomosis
patients who developed esophago-jejunal anastomotic leak and remained stable at the moment of diagnosis with no indications for diversion surgery
Disqualifiers
unstable patients who developed esophago-jejunal anastomotic leak
patients who developed esophago-jejunal anastomotic leak more than 50% or anastomotic circumference
patients who rejected endoscopic vacuum therapy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov